With the advancement of science, technology, and productivity, the rapid development of industrial production, transportation, and the exploitation of fossil fuels has gradually led to the accumulation of greenhouse gases and deterioration of global warming. Carbon neutrality is a balance between absorption and emissions achieved by minimizing carbon dioxide (CO) emissions from human social productive activity through a series of initiatives, including energy substitution and energy efficiency improvement. Then CO was offset through forest carbon sequestration and captured at last. Therefore, efficiently reducing CO emissions and enhancing CO capture are a matter of great urgency. Because many species have the natural CO capture properties, more and more scientists focus their attention on developing the biological carbon sequestration technique and further combine with synthetic biotechnology and electricity. In this article, the advances of the synthetic biotechnology method for the most promising organisms were reviewed, such as cyanobacteria, , and yeast, in which the metabolic pathways were reconstructed to enhance the efficiency of CO capture and product synthesis. Furthermore, the electrically driven microbial and enzyme engineering processes are also summarized, in which the critical role and principle of electricity in the process of CO capture are canvassed. This review provides detailed summary and analysis of CO capture through synthetic biotechnology, which also pave the way for implementing electrically driven combined strategies.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8822124PMC
http://dx.doi.org/10.3389/fbioe.2022.826008DOI Listing

Publication Analysis

Top Keywords

synthetic biotechnology
16
electrically driven
12
carbon neutrality
8
driven microbial
8
microbial enzyme
8
enzyme engineering
8
carbon sequestration
8
carbon
5
capture
5
applications synthetic
4

Similar Publications

Effect of Defined Block Sequence Terpolymers on Antifungal Activity and Biocompatibility.

Macromol Biosci

January 2025

Cluster for Advanced Macromolecular Design (CAMD) and Australian Centre for NanoMedicine (ACN), School of Chemical Engineering, UNSW, Sydney, NSW, 2052, Australia.

Invasive fungal infections cause over 3.7 million deaths worldwide annually, underscoring the critical need for new antifungal agents. Developing selective antifungal agents is challenging due to the shared eukaryotic nature of both fungal and mammalian cells.

View Article and Find Full Text PDF

Biotechnology Notes: A Year of Milestones.

Biotechnol Notes

November 2024

NUS Synthetic Biology for Clinical and Technological Innovation (SynCTI), National University of Singapore, Singapore.

View Article and Find Full Text PDF

The future of cell-free synthetic biology.

Biotechnol Notes

November 2024

Department of Chemical Engineering, Tsinghua University, Beijing 100084, China.

Cell-free synthetic biology aims at the targeted replication, design, and modification of life processes in open systems by breaking free of constraints such as cell membrane barriers and living cell growth. The beginnings of this systematized technology, which took place in the last century, were used to explore the secrets of life. Currently, with its easy integration with other technologies or disciplines, cell-free synthetic biology is developing into a powerful and effective means of understanding, exploiting, and extending the structure and function of natural living systems.

View Article and Find Full Text PDF

Polymers for mRNA Delivery.

Wiley Interdiscip Rev Nanomed Nanobiotechnol

January 2025

Shanghai Key Laboratory of Regulatory Biology, School of Life Sciences, East China Normal University, Shanghai, China.

mRNA delivery has emerged as a transformative approach in biotechnology and medicine, offering a versatile platform for the development of novel therapeutics. Unlike traditional small molecule drugs or protein-based biologics, mRNA therapeutics have the unique ability to direct cells to generate therapeutic proteins, allowing for precise modulation of biological processes. The delivery of mRNA into target cells is a critical step in realizing the therapeutic potential of this technology.

View Article and Find Full Text PDF

Candida lusitaniae is one of the fungal species which causes serious health illnesses including peritonitis, vaginitis and fungemia, among others. Several antifungal drugs have been designed to tackle its infections but their efficacy is still questionable due to their associated side effects. Hence, there is a need to design those drugs which possess comparatively higher degree of therapeutic potential.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!